Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Pevarello

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|July 17, 2009
Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitorMaria Gabriella Brasca, Nadia Amboldi, Dario Ballinari, et al.
The Journal of Biological Chemistry|August 20, 2009
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinasesWolfgang Link, Julen Oyarzabal, Beatriz G Serelde, et al.
Chemmedchem|April 24, 2007
6-Substituted pyrrolo[3,4-c]pyrazoles: an improved class of CDK2 inhibitorsMaria Gabriella Brasca, Clara Albanese, Raffaella Amici, et al.
Journal of Medicinal Chemistry|April 15, 2005
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimizationPaolo Pevarello, Maria Gabriella Brasca, Paolo Orsini, et al.
Bioorganic & Medicinal Chemistry|February 16, 2010
Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosingMaria Gabriella Brasca, Clara Albanese, Rachele Alzani, et al.
Cancer Letters|November 6, 2010
Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibitionCarmen Blanco-Aparicio, Ana María García Collazo, Julen Oyarzabal, et al.
Journal of Medicinal Chemistry|June 11, 2004
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead findingPaolo Pevarello, Maria Gabriella Brasca, Raffaella Amici, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|July 17, 2009
Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitorMaria Gabriella Brasca, Nadia Amboldi, Dario Ballinari, et al.
The Journal of Biological Chemistry|August 20, 2009
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinasesWolfgang Link, Julen Oyarzabal, Beatriz G Serelde, et al.
Chemmedchem|April 24, 2007
6-Substituted pyrrolo[3,4-c]pyrazoles: an improved class of CDK2 inhibitorsMaria Gabriella Brasca, Clara Albanese, Raffaella Amici, et al.
Journal of Medicinal Chemistry|April 15, 2005
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimizationPaolo Pevarello, Maria Gabriella Brasca, Paolo Orsini, et al.
Bioorganic & Medicinal Chemistry|February 16, 2010
Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosingMaria Gabriella Brasca, Clara Albanese, Rachele Alzani, et al.
Cancer Letters|November 6, 2010
Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibitionCarmen Blanco-Aparicio, Ana María García Collazo, Julen Oyarzabal, et al.
Journal of Medicinal Chemistry|June 11, 2004
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead findingPaolo Pevarello, Maria Gabriella Brasca, Raffaella Amici, et al.
Pageof 3